Martine A Rothblatt is of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 130 shares of UTHR, which is worth approximately $35,766. The most recent transaction as insider was on May 29, 2024, when has been sold 3,600 shares (Common Stock) at a price of $266.78 per share, resulting in proceeds of $960,407. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130
0% 3M change
0% 12M change
Total Value Held $35,766

MARTINE A ROTHBLATT Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 29 2024
SELL
Open market or private sale
$960,407 $266.78 p/Share
3,600 Reduced 96.51%
130 Common Stock
May 29 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
May 28 2024
SELL
Open market or private sale
$969,623 $269.34 p/Share
3,600 Reduced 96.51%
130 Common Stock
May 28 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
May 24 2024
SELL
Open market or private sale
$986,868 $274.13 p/Share
3,600 Reduced 96.51%
130 Common Stock
May 24 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
May 23 2024
SELL
Open market or private sale
$993,096 $275.86 p/Share
3,600 Reduced 96.51%
130 Common Stock
May 23 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
May 22 2024
SELL
Open market or private sale
$995,760 $276.6 p/Share
3,600 Reduced 96.51%
130 Common Stock
May 22 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
May 21 2024
SELL
Open market or private sale
$406,474 $276.89 p/Share
1,468 Reduced 91.86%
130 Common Stock
May 21 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
May 20 2024
SELL
Open market or private sale
$1,575,898 $274.93 p/Share
5,732 Reduced 89.17%
696 Common Stock
May 20 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
May 17 2024
SELL
Open market or private sale
$982,728 $272.98 p/Share
3,600 Reduced 96.51%
130 Common Stock
May 17 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
May 16 2024
SELL
Open market or private sale
$979,560 $272.1 p/Share
3,600 Reduced 96.51%
130 Common Stock
May 16 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
May 15 2024
SELL
Open market or private sale
$981,792 $272.72 p/Share
3,600 Reduced 96.51%
130 Common Stock
May 15 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
May 14 2024
SELL
Open market or private sale
$961,884 $267.19 p/Share
3,600 Reduced 96.51%
130 Common Stock
May 14 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
May 13 2024
SELL
Open market or private sale
$959,796 $266.61 p/Share
3,600 Reduced 96.51%
130 Common Stock
May 13 2024
BUY
Exercise of conversion of derivative security
$466,164 $129.49 p/Share
3,600 Added 49.11%
3,730 Common Stock
May 10 2024
SELL
Open market or private sale
$960,552 $266.82 p/Share
3,600 Reduced 96.51%
130 Common Stock
MAR

Martine A Rothblatt

Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR